Farallon Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-522,000	Closed	-$165M	–	189
2023 Q4	$165M	Buy	522,000 +519,800	+23,627%	+$165M	0.76%	36
2023 Q3	$372K	Hold	2,200	–	–	﹤0.01%	119
2023 Q2	$477K	Hold	2,200	–	–	﹤0.01%	127
2023 Q1	$400K	Hold	2,200	–	–	﹤0.01%	151
2022 Q4	$432K	Sell	2,200 -77,800	-97%	-$15.3M	﹤0.01%	179
2022 Q3	$18M	Sell	80,000 -20,000	-20%	-$4.5M	0.1%	99
2022 Q2	$12.7M	Sell	100,000 -250,000	-71%	-$31.6M	0.07%	119
2022 Q1	$44.4M	Sell	350,000 -200,000	-36%	-$25.4M	0.21%	73
2021 Q4	$72.1M	Sell	550,000 -150,000	-21%	-$19.7M	0.36%	52
2021 Q3	$85.6M	Buy	700,000 +70,000	+11%	+$8.56M	0.4%	56
2021 Q2	$71.8M	Sell	630,000 -45,000	-7%	-$5.13M	0.29%	58
2021 Q1	$81.2M	Sell	675,000 -25,000	-4%	-$3.01M	0.4%	53
2020 Q4	$71.1M	Hold	700,000	–	–	0.43%	55
2020 Q3	$54.1M	Buy	700,000 +125,000	+22%	+$9.67M	0.37%	60
2020 Q2	$64.1M	Buy	575,000 +7,953	+1%	+$886K	0.51%	51
2020 Q1	$40.8M	Sell	567,047 -32,953	-5%	-$2.37M	0.35%	49
2019 Q4	$45.2M	Buy	+600,000	New	+$45.2M	0.31%	56